Efficacy and Safety of the Shexiang Baoxin Pill for the Treatment of Coronary Artery Disease Not Amenable to Revascularisation: Study Protocol for a Randomised, Placebo-Controlled, Double-Blinded Trial
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2017-018052